Patents by Inventor Wujing Xian

Wujing Xian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240287533
    Abstract: The present disclosure provides methods for modifying gluten polypeptides to produce gluten polypeptides with a reduced inflammatory potential, as well as modified plants and compositions comprising modified gluten polypeptides with a reduced inflammatory potential.
    Type: Application
    Filed: June 29, 2022
    Publication date: August 29, 2024
    Applicants: The Regents of the University of California, Beth Israel Deaconess Medical Center
    Inventors: Gerard C. L. WONG, Jaime DE ANDA, Wujing XIAN, Xinhua CHEN, Ciaran KELLY
  • Publication number: 20240279313
    Abstract: The invention disclosed herein comprises peptides designed to include an amino acid sequence that confers such peptides with an ability to induce positive Gaussian curvature (and/or an ability to inhibit negative Gaussian curvature) in mammalian cell membranes. The invention disclosed herein further includes methods of using such peptides, for example as a non-hormonal contraceptive, an antiviral agent, an anti-inflammatory agent, or a therapeutic agent which can, for example, reduce neurotransmitter or hormone secretion in order to treat neuropsychiatric or endocrine disorders.
    Type: Application
    Filed: August 11, 2022
    Publication date: August 22, 2024
    Applicant: The Regents of the University of California
    Inventors: Michelle Lee, Wujing Xian, Nathan W. Schmidt, Gerard C. L. Wong
  • Publication number: 20170348337
    Abstract: Compositions and methods are disclosed that relate to aminoglycoside-linker-peptide (P-L-A) conjugates having unexpectedly advantageous dual-function bactericidal properties. Encompassed compounds are shown to be capable of energy independent bacterial plasma membrane disruption and to exhibit potent toxicity to bacteria including antibiotic-resistant bacteria. These and related embodiments will find uses for treating bacterial infections including overcoming antibiotic resistance.
    Type: Application
    Filed: August 12, 2015
    Publication date: December 7, 2017
    Applicant: The Regents of the University of California
    Inventors: Nathan W. Schmidt, Gerard C. L. Wong, Andrea Kasko, Stephanie Deshayes, Wujing Xian
  • Publication number: 20080118489
    Abstract: The invention comprises charge modified antimicrobials, including charge modified lysozymes, as well as compositions and methods for potentiating antimicrobial activity by modifying a net charge level of the antimicrobial. Also provided is a method of treating microbial infections, including infections associated with cystic fibrosis, comprising administering or co-administering a compound of the invention. The invention provides compositions and methods of potentiating antibiotic treatment by administration of an at least partially cationic or positively-charged surfactant composition. Cationic lipid compositions including DOTAP:DOPE formulations are disclosed.
    Type: Application
    Filed: October 20, 2006
    Publication date: May 22, 2008
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Gerard C. L. Wong, Wujing Xian, Lori K. Sanders, Kirstin R. Purdy